Special Talk: “Anitimalarial Lead Discovery: Exploiting phenotypic hits” by Dr. Francisco Javier Gamo Director of Malaria Discovery, GSK, Spain

Office of Research Services and Genomics and Evolutionary Medicine (GEM) coordinated by Assist Prof. Dr. Thanat Chookajorn, Faculty of Tropical Medicine , co-hosted a Special talk titled

“Anitimalarial Lead Discovery: Exploiting phenotypic hits”

by Dr. Francisco Javier Gamo , Director of Malaria Discovery, GSK, Spain

On January 30,  2017 (15.00 -16.00 hr) at Pratap Singhasivanon Conference Room, 17th floor, Rajanakarindra Building, Faculty of Tropical Medicine, Mahidol University.

59 participants attended 

Conclusion 1 (by Assist Prof. Dr. Thanat Chookajorn)

Dr. Francisco-Javier Gamo, the director of Malaria DPU at GSK, gave a presentation on “Anitimalarial Lead Discovery: Exploiting phenotypic hits”. He presented antimalarial drug development projects at GSK and discussed common challenges. For example, compounds that can kill parasites at low concentration in culture might not work in vivo. It is important to move quickly to in vivo testing in animal models. He also discussed latest approaches in drug development. One example presented at the seminar is to use microdosing in drug testing. Microdosing is a technique for studying pharmacokinetics in human by introducing low amount of a drug candidate into the system.

 

 

Gallery

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s